Overview
- POET and Lumilens announced a joint development and supply agreement that included a $50 million initial purchase order and a framework that could exceed $500 million in purchases over five years, according to the companies' May 14 disclosure.
- On May 18 POET completed a registered direct offering that raised about $400 million from a single institutional investor at a premium price, giving the company a materially larger cash balance to fund growth.
- Management said it will use the proceeds to expand wafer and optical‑engine capacity, accelerate R&D, grow its light‑source business, and pursue strategic acquisitions to support a planned production ramp.
- POET guided to ship more than 30,000 optical engines in 2026 and to begin high‑volume 800G output from its Malaysia site in Q3 2026, but analysts and investors note that revenue will hinge on successful product qualification and scaled manufacturing.
- Market coverage is mixed with bullish price targets that assume execution while shares remain volatile; the critical near‑term watch items are qualification test results, the conversion of Lumilens orders into booked revenue, and the Malaysia ramp timing.